The National Institutes of Health and guidance for reporting preclinical research

The quality of reporting clinical and preclinical research is not optimal. Reporting guidelines can help make reports of research more complete and transparent, thus increasing their value and making them more useful to all readers. Getting reporting guidelines into practice is complex and expensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Moher, David, Avey, Marc, Antes, Gerd, Altman, Douglas G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332445/
https://www.ncbi.nlm.nih.gov/pubmed/25775278
http://dx.doi.org/10.1186/s12916-015-0284-9
_version_ 1782357912707923968
author Moher, David
Avey, Marc
Antes, Gerd
Altman, Douglas G
author_facet Moher, David
Avey, Marc
Antes, Gerd
Altman, Douglas G
author_sort Moher, David
collection PubMed
description The quality of reporting clinical and preclinical research is not optimal. Reporting guidelines can help make reports of research more complete and transparent, thus increasing their value and making them more useful to all readers. Getting reporting guidelines into practice is complex and expensive, and involves several stakeholders, including prospective authors, peer reviewers, journal editors, guideline developers, and implementation scientists. Working together will help ensure their maximum uptake and penetration. We are all responsible for helping to ensure that all research is reported so completely that it is of value to everybody. Please see related article: http://dx.doi.org/10.1186/s12916-015-0266-y
format Online
Article
Text
id pubmed-4332445
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43324452015-02-19 The National Institutes of Health and guidance for reporting preclinical research Moher, David Avey, Marc Antes, Gerd Altman, Douglas G BMC Med Commentary The quality of reporting clinical and preclinical research is not optimal. Reporting guidelines can help make reports of research more complete and transparent, thus increasing their value and making them more useful to all readers. Getting reporting guidelines into practice is complex and expensive, and involves several stakeholders, including prospective authors, peer reviewers, journal editors, guideline developers, and implementation scientists. Working together will help ensure their maximum uptake and penetration. We are all responsible for helping to ensure that all research is reported so completely that it is of value to everybody. Please see related article: http://dx.doi.org/10.1186/s12916-015-0266-y BioMed Central 2015-02-17 /pmc/articles/PMC4332445/ /pubmed/25775278 http://dx.doi.org/10.1186/s12916-015-0284-9 Text en © Moher et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Moher, David
Avey, Marc
Antes, Gerd
Altman, Douglas G
The National Institutes of Health and guidance for reporting preclinical research
title The National Institutes of Health and guidance for reporting preclinical research
title_full The National Institutes of Health and guidance for reporting preclinical research
title_fullStr The National Institutes of Health and guidance for reporting preclinical research
title_full_unstemmed The National Institutes of Health and guidance for reporting preclinical research
title_short The National Institutes of Health and guidance for reporting preclinical research
title_sort national institutes of health and guidance for reporting preclinical research
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332445/
https://www.ncbi.nlm.nih.gov/pubmed/25775278
http://dx.doi.org/10.1186/s12916-015-0284-9
work_keys_str_mv AT moherdavid thenationalinstitutesofhealthandguidanceforreportingpreclinicalresearch
AT aveymarc thenationalinstitutesofhealthandguidanceforreportingpreclinicalresearch
AT antesgerd thenationalinstitutesofhealthandguidanceforreportingpreclinicalresearch
AT altmandouglasg thenationalinstitutesofhealthandguidanceforreportingpreclinicalresearch
AT moherdavid nationalinstitutesofhealthandguidanceforreportingpreclinicalresearch
AT aveymarc nationalinstitutesofhealthandguidanceforreportingpreclinicalresearch
AT antesgerd nationalinstitutesofhealthandguidanceforreportingpreclinicalresearch
AT altmandouglasg nationalinstitutesofhealthandguidanceforreportingpreclinicalresearch

Ejemplares similares